Congenital brain anomalies cause a spectrum of neurologic deficits; although some may cause no clinically significant effects, others may be fatal.
Some of the most serious neurologic anomalies (eg, anencephaly, encephalocele, spina bifida) develop in the first 2 months of gestation and represent defects in neural tube formation (dysraphism). Others, such as lissencephaly, result from problems with neuronal migration (see Malformed Cerebral Hemispheres), which occurs between 9 weeks and 24 weeks of gestation. Hydranencephaly and porencephaly are secondary to destructive processes that occur after the basic architecture of the brain has formed. Some anomalies (eg, meningocele) may be relatively benign.
There are many causes of congenital brain anomalies, including many still unknown genetic factors. Next-generation sequencing techniques, such as genetic panels and whole exome sequencing, have revealed a large number of genetic causes of these anomalies.
Prenatal ultrasound can screen for major brain malformations in utero. Fetal MRI techniques are increasingly useful, mainly when ultrasound findings are of concern. Genetic causes are typically not discerned prenatally. Fetal genetic testing can be performed via maternal cell-free DNA testing, chorionic villous sampling, or amniocentesis. Karyotyping can identify large chromosomal rearrangements and copy number variants. Advanced genetic testing options to detect gene mutations that cause some cortical malformation syndromes, such as somatic mutations, are limited.
When a congenital neurologic anomaly is detected, parents should be counseled about the impacts of the malformation on a child and be offered psychological support, if appropriate. Genetic counseling should be offered and genetic testing of the parent and child should be considered because the recurrence risk of a related malformation may be as high as 25 to 50%, depending on the inheritance pattern.
Prevention of Congenital Neurologic Anomalies
To reduce risk of fetal neural tube defects, as part of preconception care women of reproductive age who are planning pregnancy or who may become pregnant (ie, sexually active with inconsistent use of contraception) should take folate daily, starting 3 months before conception and continuing through the first trimester.
For most women, the recommended dose of folate is 400 to 800 mcg (0.4 to 0. 8 mg) orally once a day.
For women with a prior history of having a fetus or infant with a neural tube defect, the recommended daily dose of folate is 4000 mcg (4 mg) (1). The risk of a neural tube defect in future pregnancies is reduced by folate supplementation by approximately 70% (2).
Prevention references
1. Shaw GM, O'Malley CD, Wasserman CR, et al. Maternal periconceptional use of multivitamins and reduced risk for conotruncal heart defects and limb deficiencies among offspring. Am J Med Genet. 1995;59(4):536-545. doi:10.1002/ajmg.1320590428
2. Grosse SD, Collins JS. Folic acid supplementation and neural tube defect recurrence prevention. Birth Defects Res A Clin Mol Teratol. 2007;79(11):737-742. doi:10.1002/bdra.20394
